BIOMAT Database Logo BIOMAT Database Logo

Anti-tetanus human monoclonal antibodies. 1990

M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
Department of Tuberculosis Research, Osaka University.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
Characterization of Neutralizing Human Anti-Tetanus Monoclonal Antibodies Produced by Stable Cell Lines.
September 2022, Pharmaceutics,
M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
Feasibility studies of large scale production of human anti-tetanus toxoid monoclonal antibodies.
January 1999, Journal of biotechnology,
M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
Novel neutralizing human monoclonal antibodies against tetanus neurotoxin.
June 2021, Scientific reports,
M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
[Human monoclonal anti-cytomegalovirus antibodies].
January 1987, Annales de medecine interne,
M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
Effective production of anti-tetanus toxoid and anti-HBsAg human monoclonal antibodies by serum-free culture of hybridomas.
January 1991, Cytotechnology,
M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
Effective production of anti-tetanus toxoid and anti-HBsAg human monoclonal antibodies by serum-free culture of hybridomas.
January 1991, Cytotechnology,
M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
Human monoclonal antibodies with a protective activity against tetanus toxin.
August 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
Neutralization of tetanus toxin by human monoclonal antibodies directed against tetanus toxin fragment C.
December 1993, Hybridoma,
M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
Polyreactivity of human monoclonal antibodies: human IgM anti-rhesus monoclonal antibodies are frequently polyreactive.
January 1996, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
M Matsuda, and M Kamei, and S Hashizume, and N Sugimoto
Human monoclonal anti-DNA antibodies react as lymphocytotoxic antibodies.
October 1985, European journal of immunology,
Copied contents to your clipboard!